AI assistant
Sending…
Purple Biotech Ltd. — Board/Management Information 2016
Jan 10, 2016
7004_rns_2016-01-10_0aa8c81b-692e-41ac-81ec-0a10fe347a2d.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________ false
C002����� ����� ������ ��"�2PublicKITOV PHARMACEUTICALS HOLDINGS LTD10994Corporation no: 520031238Stock Exchange/Market: -1360380Menachem Begin St, Azrieli Towers Round Tower 132, Floor 23 , Tel Aviv 6701101 , ,Tel: 03-5750547 , Fax: 077-3180015E.mail address: [email protected] via MAGNA: 10/01/2016 Time of broadcast: 09:20 09:13:37
| Company site: | www.kitovpharma.com |
Reference: 2016-02-006688
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Press Release: �Kitov Pharmaceuticals Appoints Dr. Gil Ben-Menachem as V.P. of Business Development� |
| Kitov_Pharmaceuticals_Holdings_Ltd_6-K_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, |
| Date of revision of form structure: 31/12/2015 |
| - - - |
| Name of the Signatory: : BEN-TZVI ABRAHAM SHLOMO , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: . |
| Menachem Begin St, Azrieli Towers Round Tower Telephone: 054-8679966 , Facsimile: 077-3180015 , E-mail: [email protected] 1 |
More from Purple Biotech Ltd.
Report Publication Announcement
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Apr 27
Report Publication Announcement
2026
Apr 27
Report Publication Announcement
2026
Apr 23
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 17
Director's Dealing
2026
Apr 17